ResMed Inc.
RMD
$208.05
-$0.93-0.45%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.28% | 9.57% | 9.36% | 9.84% | 9.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.28% | 9.57% | 9.36% | 9.84% | 9.54% |
| Cost of Revenue | 2.65% | 3.01% | 3.16% | 3.12% | 2.34% |
| Gross Profit | 15.51% | 14.12% | 13.79% | 14.84% | 15.08% |
| SG&A Expenses | 11.54% | 9.72% | 8.36% | 8.06% | 5.73% |
| Depreciation & Amortization | 5.84% | 3.90% | 1.19% | -2.64% | -6.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.97% | 5.53% | 5.11% | 4.78% | 3.47% |
| Operating Income | 19.41% | 18.27% | 18.89% | 21.91% | 25.05% |
| Income Before Tax | 20.67% | 18.48% | 26.51% | 32.64% | 33.23% |
| Income Tax Expenses | 45.36% | 16.26% | 15.10% | 13.53% | 17.07% |
| Earnings from Continuing Operations | 15.71% | 18.99% | 29.21% | 37.20% | 37.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.71% | 18.99% | 29.21% | 37.20% | 37.03% |
| EBIT | 19.41% | 18.27% | 18.89% | 21.91% | 25.05% |
| EBITDA | 20.11% | 18.26% | 18.76% | 21.31% | 22.43% |
| EPS Basic | 16.40% | 19.47% | 29.56% | 37.48% | 37.23% |
| Normalized Basic EPS | 22.84% | 21.33% | 23.21% | 27.03% | 30.43% |
| EPS Diluted | 16.39% | 19.37% | 29.43% | 37.26% | 36.88% |
| Normalized Diluted EPS | 22.91% | 21.37% | 23.17% | 26.93% | 30.27% |
| Average Basic Shares Outstanding | -0.59% | -0.40% | -0.29% | -0.21% | -0.15% |
| Average Diluted Shares Outstanding | -0.64% | -0.43% | -0.25% | -0.11% | -0.03% |
| Dividend Per Share | 12.56% | 11.88% | 11.17% | 10.42% | 10.11% |
| Payout Ratio | -0.03% | -0.06% | -0.14% | -0.20% | -0.20% |